ATC Group: D01AC02 Miconazole

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of D01AC02 in the ATC hierarchy

Level Code Title
1 D Dermatologicals
2 D01 Antifungals for dermatological use
3 D01A Antifungals for topical use
4 D01AC Imidazole and triazole derivatives
5 D01AC02 Miconazole

Active ingredients in D01AC02

Active Ingredient Description
Miconazole

Miconazole possesses an antifungal activity against the common dermatophytes and yeasts as well as an antibacterial activity against certain gram-positive bacilli and cocci. Its activity is based on the inhibition of the ergosterol biosynthesis in fungi and the change in the composition of the lipid components in the membrane, resulting in fungal cell necrosis.

Related product monographs

Title Information Source Document Type  
CANDIPLAS Cream Υπουργείο Υγείας (CY) MPI, EU: SmPC
DAKTARIN Cream Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
DAKTARIN Oral gel Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
GYNO-DAKTARIN Vaginal cream Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Estonia (EE)

Finland (FI)

France (FR)

Germany (DE)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Nigeria (NG)

Poland (PL)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.